Amgen
AMGN
£215.00
Share price
-1.77%
Change (1 day)
-11.54%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) - P/B ratio
P/B ratio as of July 2025 : 25.8
According to Amgen's latest financial reports the company has a price-to-book ratio of 4.69922.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Amgen - P/B ratio (from 2001 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 24.0 | -2.87% |
| 2023-12-31 | 24.7 | -35.38% |
| 2022-12-31 | 38.3 | 102.39% |
| 2021-12-31 | 18.9 | 32.95% |
| 2020-12-31 | 14.2 | -3.48% |
| 2019-12-31 | 14.7 | 50.32% |
| 2018-12-31 | 9.81 | 96.05% |
| 2017-12-31 | 5.00 | 37.37% |
| 2016-12-31 | 3.64 | -16.46% |
| 2015-12-31 | 4.36 | -7.24% |
| 2014-12-31 | 4.70 | 20.61% |
| 2013-12-31 | 3.90 | 13.9% |
| 2012-12-31 | 3.42 | 15.64% |
| 2011-12-31 | 2.96 | 38.41% |
| 2010-12-31 | 2.14 | -13.94% |
| 2009-12-31 | 2.48 | -16.28% |
| 2008-12-31 | 2.97 | 4.99% |
| 2007-12-31 | 2.83 | -32.74% |
| 2006-12-31 | 4.20 | -11.01% |
| 2005-12-31 | 4.72 | 15.06% |
| 2004-12-31 | 4.10 | 0.27% |
| 2003-12-31 | 4.09 | 20.05% |
| 2002-12-31 | 3.41 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.59 | -93.84% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.47 | -78.82% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 4.38 | -83.06% | 🇬🇧 UK |
 Gilead Sciences GILD | 7.29 | -71.79% | 🇺🇸 USA |
 Biogen BIIB | 1.15 | -95.56% | 🇺🇸 USA |
 AbbVie ABBV | 229 | 785.15% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 4.81 | -81.40% | 🇺🇸 USA |
 Illumina ILMN | 6.74 | -73.92% | 🇺🇸 USA |
 Eli Lilly LLY | 44.2 | 71.18% | 🇺🇸 USA |